Effect of chitosan nanoparticles loaded with platelet lysate on in vitro fertilization and early embryo development in a mouse premature ovarian failure model

Document Type : Original Article

Authors

1 Department of Anatomy and Cell Biology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2 Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran

3 Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

10.22038/ijbms.2025.84330.18249

Abstract

Objective(s): Premature ovarian failure (POF) is a common cause of women’s infertility. Cyclophosphamide (CP) is one of the most important gonadotoxic agents that lead to POF. This study aimed to evaluate the potential therapeutic effect of chitosan nanoparticles loaded with platelet lysate (PLCH NPs) on in vitro fertilization (IVF) outcome and early embryo development in a model of CP-induced POF.
Materials and Methods: In this study, synthesized nanoparticles were developed based on the ionic gelation method and characterized by the physicochemical properties of particle size, zeta potential, FTIR, microscopic studies, drug encapsulation, and in vitro drug release. Sixty female BALB/c mice were randomly assigned into six groups: Control, sham, POF, POF-PL, POF-CH, and POF-PLCH. Finally, the PLCH NPs were examined for their therapeutic potential against CP-induced POF by evaluating Anti-Müllerian hormone (AMH) levels, malondialdehyde (MDA) levels, total anti-oxidant capacity (TAC), fertilization rate, and embryo development.
Results: The results showed that PL’s in vitro release profile has a sustained release pattern. The treatment of PLCH NPs in POF mice increased AMH and TAC and decreased MDA levels compared to the control group (P<0.05). The mean number of retrieved oocytes, cleavage and fertilization rates, and blastocyst formation rates were significantly increased in the POF-PLCH group compared with the POF group (P<0.05).
Conclusion: This study proposes a novel PLCH NP-mediated combination therapy for the clinical treatment of POF and shows that PLCH NPs are superior to free PL in terms of effectiveness.

Keywords

Main Subjects

References

1. Akbaribazm M, Goodarzi N, Rahimi M. Female infertility and herbal medicine: An overview of the new findings. Food Sci Nutr 2021; 9: 5869–5882. 
2. Atkinson L, Martin F, Sturmey RG. Intraovarian injection of platelet-rich plasma in assisted reproduction: Too much too soon? Hum Reprod 2021; 36: 1737–1750. 
3. Wu JX, Xia T, She LP, Lin S, Luo XM. Stem cell therapies for human infertility: Advantages and challenges. Cell Transplant 2022; 31: 1–14.
4. Vo TKC, Tanaka Y, Kawamura K. Ovarian rejuvenation using autologous platelet-rich plasma. Endocrines 2021; 2: 15–27. 
5. Shareghi-oskoue O, Aghebati-Maleki L, Yousefi M. Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure. Stem Cell Res Ther 2021; 12: 1–13.
6. Yao Y, Xu Y, Wang Y. Protective roles and mechanisms of rosmarinic acid in cyclophosphamide-induced premature ovarian failure. J Biochem Mol Toxicol 2020; 34: 1–9. 
7. Bhoi NR, Chandra V, Johari C, Murdia K. Assisted Reproductive Technology ( ART ): A ray of hope for adolescent idiopathic premature ovarian failure case presentation 2023; 15: 10–13. 
8. Lin J, Wu D, Jia L, Liang M, Liu S, Qin Z, et al. The Treatment of complementary and alternative medicine on premature ovarian failure 2021; 2021: 1–14. 
9. Anagani M, Agrawal P, Reddy BV, Mishra PC. Role of autologous bone marrow derived stem cells and platelet rich plasma for endometrial regeneration and repair and ovarian rejuvenation. Int J Reprod Contraception, Obstet Gynecol 2021; 10: 597–604.
10. Rinaudo P, Albertini D. Will PRP therapy find a niche in reproductive medicine? Not ready for prime time. J Assist Reprod Genet 2021; 38: 1013–1024. 
11. Dominika S, Aleksandra K, Karolina F, Magdalena E, Jakub G, Konrad F. Platelet rich plasma. Gynecology 2022; 19: 5284–5295. 
12. Vo TKC, Tanaka Y, Kawamura K. Ovarian rejuvenation using autologous platelet-rich plasma. Endocrines 2021; 2: 15–27. 
13. Sharara FI, Lelea LL, Rahman S, Klebanoff JS, Moawad GN. A narrative review of platelet-rich plasma (PRP) in reproductive medicine. J Assist Reprod Genet 2021; 38: 1003–1012. 
14. Budak Ö, Bostancl MS, Toprak V, Doǧanay S, Köse O. Protective effects of Platelet-rich plasma for in vitro fertilization of rats with ovarian failure induced by cyclophosphamide. Rev Bras Ginecol e Obstet 2022; 44: 161–168. 
15. Navali N, Sadeghi L, Farzadi L, Ghasemzadeh A, Hamdi K, Hakimi P, et al. Correction: Intraovarian injection of autologous Platelet-Rich Plasma improves therapeutic approaches in the patients with poor ovarian response: A before-after study. Int J Fertil Steril 2022; 16: 90–94. 
16. Abdelrahman TA, Motawea A, El-Dahhan MS, Abdelghani GM. Chitosan-dipotassium orthophosphate lyophilizate: A novel in situ thermogel carrier system of allogeneic platelet lysate growth factors. Drug Deliv 2022; 29: 413–426. 
17. Athanasios G, Efstathios M, Panagiotis M, Eros N. Rejuvenation of ovarian function after autologous platelet lysate injection: Promising evidence from confirmed cases. Clin J Obstet Gynecol 2023; 6: 225–232. 
18. Sills ES, Rickers NS, Li X, Palermo GD. First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma. Gynecol Endocrinol 2018; 34: 756–760. 
19. Divya P. Platelet-rich plasma in female infertility: A comprehensive review of current literature. Fertil Sci Res 2021; 8: 1–30. 
20. Selvaraj Y, Malaisamy K. Rejuvenation of ovary and thin endometrium by autologous PRP injection in POR and recurrent implantation failure. Adv Sex Med 2021; 11: 1–15. 
21. Peterson JE, Zurakowski D, Italiano JE, Michel L V., Fox L, Klement GL, et al. Normal ranges of angiogenesis regulatory proteins in human platelets. Am J Hematol 2010; 85: 487–493. 
22. Hajipour H, Farzadi L, Latifi Z, Keyhanvar N, Navali N, Fattahi A, et al. An update on platelet-rich plasma (PRP) therapy in endometrium and ovary related infertilities: clinical and molecular aspects. Syst Biol Reprod Med 2021; 67:177–188. 
23. Aflatoonian A, Lotfi M, Saeed L, Tabibnejad N. Effects of intraovarian injection of autologous platelet-rich plasma on ovarian rejuvenation in poor responders and women with primary ovarian insufficiency. Reprod Sci 2021; 28: 2050–2059. 
24. Taysi AE, Cevher E, Sessevmez M, Olgac V, Taysi NM, Atalay B. The efficacy of sustained-release chitosan microspheres containing recombinant human parathyroid hormone on mronj. Braz Oral Res 2019; 33: 1–13. 
25. Roy S, Rhim JW. Fabrication of chitosan-based functional nanocomposite films: Effect of quercetin-loaded chitosan nanoparticles. Food Hydrocoll 2021; 121: 1–11.
26. Yang Z, Hong W, Zheng K, Feng J, Hu C, Tan J, et al. Chitosan oligosaccharides alleviate H2O2-stimulated granulosa cell damage via HIF-1 α signaling pathway. Oxid Med Cell Longev 2022; 2022: 1–15. 
27. Singh A, Mittal A, Benjakul S. Chitosan nanoparticles: Preparation, food applications and health benefits. ScienceAsia 2021; 47: 1–10. 
28. Jhanvi Jhaveri, Zarna Raichura, Tabassum Khan, Munira Momin, AbdelWahab Omri. Chitosan nanoparticles-insight into properties, functionalizationand applications in drug delivery and theranostics. Molecules 2021; 26: 272–301.
29. Altindağ F, Özdek U. Protective effects of chitosan and chitosan oligosaccharide on sodium fluoride-induced testicular damage in male rats: A stereological and histopathological study. Kafkas Univ Vet Fak Derg 2021; 27: 183–189. 
30. Nazarnezhad S, Kermani F, Askari VR, Hosseini SA, Ebrahimzadeh-Bideskan A, Moradi A, et al. Preparation and characterization of platelet lysate (Pl)-loaded electrospun nanofibers for epidermal wound healing. J Pharm Sci 2022; 111: 2531–2539.
31. Luan Y, Edmonds ME, Woodruff TK, Kim SY. Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide. J Endocrinol 2019; 240: 243–256. 
32. Ahmadian S, Sheshpari S, Pazhang M, Bedate AM, Beheshti R, Abbasi MM, et al. Intra-ovarian injection of platelet-rich plasma into ovarian tissue promoted rejuvenation in the rat model of premature ovarian insufficiency and restored ovulation rate via angiogenesis modulation. Reprod Biol Endocrinol 2020; 18: 1–13. 
33. Wang D, Geng M, Gan D, Han G, Gao G, Xing A, et al. Effect of resveratrol on mouse ovarian vitrification and transplantation. Reprod Biol Endocrinol 2021; 19: 1–13. 
34. Qin X, Zhao Y, Zhang T, Yin C, Qiao J, Guo W, et al. TrkB agonist antibody ameliorates fertility deficits in aged and cyclophosphamide-induced premature ovarian failure model mice. Nat Commun 2022; 13: 1–17. 
35. Cevher E, Salomon SK, Makrakis A, Li XW, Brocchini S, Alpar HO. Development of chitosan-pullulan composite nanoparticles for nasal delivery of vaccines: Optimisation and cellular studies. J Microencapsul 2015; 32: 755–768. 
36. Lu B, Wang T, Li Z, Dai F, Lv L, Tang F, et al. Healing of skin wounds with a chitosan-gelatin sponge loaded with tannins and platelet-rich plasma. Int J Biol Macromol 2016; 82: 884–891. 
37. Nokhodi F, Nekoei M, Goodarzi MT. Hyaluronic acid-coated chitosan nanoparticles as targeted-carrier of tamoxifen against MCF7 and TMX-resistant MCF7 cells. J Mater Sci Mater Med 2022; 33: 24 –37. 
38. Yoon SY, Yoon JA, Park M, Shin EY, Jung S, Lee JE, et al. Recovery of ovarian function by human embryonic stem cell-derived mesenchymal stem cells in cisplatin-induced premature ovarian failure in mice. Stem Cell Res Ther 2020; 11: 1 –13. 
39. Zhang Y, Ouyang X, You S, Zou H, Shao X, Zhang G, et al. Effect of human amniotic epithelial cells on ovarian function, fertility and ovarian reserve in primary ovarian insufficiency rats and analysis of underlying mechanisms by mRNA sequencing. Am J Transl Res 2020; 12: 3234–3254. 
40. Zhou F, Song Y, Liu X, Zhang C, Li F, Hu R, et al. Si-Wu-Tang facilitates ovarian function through improving ovarian microenvironment and angiogenesis in a mouse model of premature ovarian failure. J Ethnopharmacol 2021; 280: 1–12. 
41. Rajabzadeh AR, Eimani H, Koochesfahani HM, Shahvardi AH, Fathi R. Morphological study of isolated ovarian preantral follicles using fibrin gel plus platelet lysate after subcutaneous transplantation. Cell J 2015; 17: 145–152. 
42. Jiao Y, Niu Y, Luo M, Qiu Y, Gao M, Chen X, et al. Chitosan microspheres loaded with WJMSCs facilitate the restoration of ovarian function in CTX-induced premature ovarian failure mice. MedComm - Biomater Appl 2023; 2: 1–14. 
43. Badawy A, Sobh MA, Ahdy M, Abdelhafez MS. Bone marrow mesenchymal stem cell repair of cyclophosphamide-induced ovarian insufficiency in a mouse model. Int J Womens Health 2017; 9: 441–447. 
44. Delkhosh A, Delashoub M, Tehrani AA, Bahrami AM, Niazi V, Shoorei H, et al. Upregulation of FSHR and PCNA by administration of coenzyme Q10 on cyclophosphamide-induced premature ovarian failure in a mouse model. J Biochem Mol Toxicol 2019; 33: 1–12. 
45. Cozzolino M, Ergun Y, Seli DA, Herraiz S. Intraovarian PRP injection improves oocyte quality and early embryo development in mouse models of chemotherapy-induced diminished ovarian reserve. Aging 2024; 16: 12123–12137. 
46. Tran DN, Jung EM, Yoo YM, Ahn C, Kang HY, Choi KC, et al. Depletion of follicles accelerated by combined exposure to phthalates and 4-vinylcyclohexene diepoxide, leading to premature ovarian failure in rats. Reprod Toxicol 2018; 80: 60–67. 
47. Xu H, Bao X, Kong H, Yang J, Li Y, Sun Z. Melatonin protects against cyclophosphamide-induced premature ovarian failure in rats. Hum Exp Toxicol 2022; 41: 1–9. 
48. Pascuali N, Scotti L, Di Pietro M, Oubiña G, Bas D, May M, et al. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure. Hum Reprod 2018; 33: 844–859. 
49. Bandariyan E, Mogheiseh A, Ahmadi A. The effect of lutein and Urtica dioica extract on in vitro production of embryo and oxidative status in polycystic ovary syndrome in a model of mice. BMC Complement Med Ther 2021; 21: 1–11. 
50. Moradi S, Khazaei M, Rashidi Z. Synergistic effects of capsaicin and quercetin improved induced premature ovarian failure in rat. Cell J 2023; 25: 496–504. 
 
Iranian Journal of Basic Medical Sciences
Volume 28, Issue 7
July 2025
Pages 937-945

Files

Share

How to cite

Statistics